TechFlow, August 25 — According to Prnewswire, Galmed Pharmaceuticals Ltd., a biopharmaceutical company listed on the U.S. stock market, announced the implementation of a digital asset management strategy. The company plans to allocate $10 million (approximately 50% of its current cash reserves) toward investments in digital assets.
The company has established a cryptocurrency committee responsible for evaluating and overseeing cryptocurrency-related investment activities. The strategy will include portfolio rebalancing of digital assets, participation in liquidity provision, staking yield, and risk hedging strategies. To execute this plan, Galmed has signed a letter of intent with Tectona (TASE: TECT), a cryptocurrency asset management service provider, which will offer advisory and operational services.
